General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research. The company has signed an exclusive license and alliance pact with Geron Corporation (NASDAQ: GERN). The aim here is to develop and commercialize cellular assay ... Read more